Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$831M |
| 2 |
Palo Alto Networks
PANW
|
$348M |
| 3 |
Visa
V
|
$347M |
| 4 |
Citigroup
C
|
$296M |
| 5 |
CELG
Celgene Corp
CELG
|
$295M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$638M |
| 2 |
EOG Resources
EOG
|
$322M |
| 3 |
Canadian Pacific Kansas City
CP
|
$305M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$289M |
| 5 |
JD.com
JD
|
$283M |
Sector Composition
| 1 | Healthcare | 19.11% |
| 2 | Consumer Discretionary | 17.28% |
| 3 | Communication Services | 14.32% |
| 4 | Technology | 13.24% |
| 5 | Financials | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Thermo Fisher Scientific
TMO
$186B
| $56.6M | 0.06% |
462,805
-151,357
| -25% | -$18.5M |
|
277
RH
RH
$4.7B
| $56.5M | 0.06% |
605,908
-113,241
| -16% | -$10.6M |
|
278
WESCO International
WCC
$10.7B
| $56.2M | 0.06% |
1,209,848
-476,386
| -28% | -$22.1M |
|
|
CPN
279
DELISTED
Calpine Corporation
CPN
| $56.2M | 0.06% |
3,848,463
-838,617
| -18% | -$12.2M |
|
|
ESRX
280
DELISTED
Express Scripts Holding Company
ESRX
| $55.9M | 0.06% |
690,758
+329,073
| +91% | +$26.6M |
|
281
Amicus Therapeutics
FOLD
$2.46B
| $55.8M | 0.06% |
3,990,817
+618,822
| +18% | +$8.66M |
|
282
Live Nation Entertainment
LYV
$37.9B
| $55.7M | 0.06% |
2,316,739
+228,739
| +11% | +$5.5M |
|
283
Guidewire Software
GWRE
$22B
| $55.5M | 0.06% |
1,055,461
+48,560
| +5% | +$2.55M |
|
284
Pebblebrook Hotel Trust
PEB
$1.4B
| $55.2M | 0.06% |
1,556,354
-83,852
| -5% | -$2.97M |
|
285
Bausch Health
BHC
$2.72B
| $55M | 0.06% |
308,200
+2,364
| +0.8% | +$422K |
|
|
RYL
286
DELISTED
RYLAND GROUP INC
RYL
| $54.6M | 0.06% |
1,337,893
+389,338
| +41% | +$15.9M |
|
287
Avient
AVNT
$3.45B
| $54.3M | 0.06% |
1,851,462
-95,099
| -5% | -$2.79M |
|
288
Texas Instruments
TXN
$171B
| $54.2M | 0.06% |
+1,094,310
| New | +$54.2M |
|
289
Range Resources
RRC
$8.27B
| $53.7M | 0.06% |
1,670,846
-86,388
| -5% | -$2.77M |
|
|
CEB
290
DELISTED
CEB Inc.
CEB
| $53.1M | 0.05% |
777,214
-10,406
| -1% | -$711K |
|
|
NFX
291
DELISTED
Newfield Exploration
NFX
| $52.7M | 0.05% |
1,602,580
+218,509
| +16% | +$7.19M |
|
292
Clearway Energy Class C
CWEN
$3.38B
| $52.4M | 0.05% |
4,517,350
-17,979
| -0.4% | -$209K |
|
293
NN Inc
NNBR
$125M
| $52.4M | 0.05% |
2,833,931
+382,222
| +16% | +$7.07M |
|
|
CSOD
294
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $52M | 0.05% |
1,577,115
+136,111
| +9% | +$4.49M |
|
295
Curtiss-Wright
CW
$18.1B
| $51.8M | 0.05% |
830,399
-61,107
| -7% | -$3.81M |
|
|
DBD
296
DELISTED
Diebold Nixdorf Incorporated
DBD
| $51.7M | 0.05% |
1,735,674
+378,038
| +28% | +$11.3M |
|
297
Chevron
CVX
$310B
| $51.7M | 0.05% |
654,859
-7,659
| -1% | -$604K |
|
|
CMCSK
298
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $51.6M | 0.05% |
901,291
-136,824
| -13% | -$7.83M |
|
299
Exelon
EXC
$43.9B
| $51.4M | 0.05% |
2,428,582
-1,805,415
| -43% | -$38.2M |
|
300
TechnipFMC
FTI
$16B
| $51.3M | 0.05% |
2,222,172
+625,397
| +39% | +$14.4M |
|